Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-04-14

Clinical Trial Update: Low-Dose Naltrexone and Acetaminophen Combination and Its Components in the Acute Treatment of Migraine [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a low-dose naltrexone and acetaminophen combination for acute treatment of migraine has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Acetaminophen (Acetaminophen)
  • Naltrexone (Naltrexone)
  • Naltrexone/Acetaminophen combination

Snippet

Sponsor: Allodynic Therapeutics, Inc | Conditions: Migraine With or Without Aura | Phase 2 | Status: COMPLETED